Nanoparticles-based anti-aging treatment of Alzheimer’s disease

Age is the strongest risk factor for Alzheimer’s disease (AD). In recent years, the relationship between aging and AD has been widely studied, with anti-aging therapeutics as the treatment for AD being one of the mainstream research directions. Therapeutics targeting senescent cells have shown impro...

Descripción completa

Detalles Bibliográficos
Autores principales: Chu, Jian-Jian, Ji, Wen-Bo, Zhuang, Jian-Hua, Gong, Bao-Feng, Chen, Xiao-Han, Cheng, Wen-Bin, Liang, Wen-Danqi, Li, Gen-Ru, Gao, Jie, Yin, You
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9302016/
https://www.ncbi.nlm.nih.gov/pubmed/35850622
http://dx.doi.org/10.1080/10717544.2022.2094501

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9302016/
https://www.ncbi.nlm.nih.gov/pubmed/35850622
http://dx.doi.org/10.1080/10717544.2022.2094501

Ejemplares similares